What is the evaluation approach for an upper gastrointestinal (GI) bleed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation of Upper Gastrointestinal Bleeding

Endoscopy is the first-line diagnostic and therapeutic procedure for upper GI bleeding and should be performed within 24 hours of presentation in most patients, with urgent endoscopy (within 6 hours) reserved for hemodynamically unstable patients. 1, 2, 3

Initial Clinical Assessment and Risk Stratification

Use the Glasgow-Blatchford score immediately upon presentation to stratify bleeding risk. 4, 3

  • Patients with Glasgow-Blatchford score of 0-1 can be safely discharged with outpatient follow-up without inpatient endoscopy. 3, 5
  • Patients with scores ≥12 indicate high risk for further bleeding or death and require hospitalization. 6
  • Document any observed bleeding by photographing emesis basins, bedsheets, or toilet bowls to confirm symptoms. 2

Laboratory Evaluation

Obtain the following tests immediately: 4

  • Complete blood count
  • Basic metabolic panel
  • Coagulation panel
  • Liver function tests
  • Type and crossmatch

Resuscitation Protocol

Transfuse packed red blood cells at a hemoglobin threshold of 7 g/dL (or 9 g/dL in patients with massive bleeding or significant cardiovascular comorbidities). 2, 4, 7

  • Rapidly infuse normal saline or lactated Ringer solution to correct hypovolemia and maintain blood pressure. 4
  • Initiate proton pump inhibitor therapy immediately upon presentation. 4, 7, 3
  • Consider erythromycin infusion before endoscopy to improve visualization. 3

Endoscopic Evaluation

Perform esophagogastroduodenoscopy (EGD) within 24 hours for most hospitalized patients. 1, 2, 6, 3

  • For hemodynamically unstable patients, perform urgent endoscopy within 6 hours after resuscitation. 2, 7
  • However, note that a high-quality 2020 randomized trial found no mortality benefit from endoscopy within 6 hours versus 6-24 hours in high-risk patients (30-day mortality 8.9% vs 6.6%, difference not significant). 6
  • Endoscopy provides both diagnostic capability and therapeutic intervention for bleeding lesions. 2, 4

Common lesions to identify during endoscopy include: 1, 2

  • Cameron's erosions in large hiatal hernias
  • Fundic varices
  • Peptic ulcer disease
  • Angioectasias
  • Dieulafoy's lesion
  • Gastric antral vascular ectasia

When Endoscopy is Negative or Contraindicated

If initial endoscopy is negative but bleeding persists (obscure bleeding), proceed with the following algorithm: 1

For Active Ongoing Bleeding:

CT angiography (CTA) is the preferred next step when endoscopy fails to identify a source. 1

  • CTA can detect bleeding rates as slow as 0.3 mL/min with sensitivity of 79% and specificity of 95%. 1
  • Multiphase CT protocol is essential: noncontrast, late arterial, and venous phases. 1
  • Critical caveat: Avoid oral contrast as it obscures active hemorrhage and interferes with subsequent procedures. 1
  • In high-risk patients (requiring ≥500 mL transfusion), CTA sensitivity is 81%, dropping to 50% in slower bleeds. 1

Visceral arteriography is an alternative that allows simultaneous therapeutic embolization. 1

  • Can detect bleeding rates as low as 0.5 mL/min. 1
  • Angiography identified bleeding in 72-80% of patients with overt nonvariceal UGIB. 1
  • Early angiography (within first 5 hours) significantly improves visualization of extravasation. 1
  • Limitation: Cannot detect venous bleeding and may miss intermittent bleeding. 1

For Postsurgical or Traumatic Bleeding When Endoscopy is Contraindicated:

Primary angiographic evaluation should be preferred over endoscopy. 1

  • This applies to patients with new anastomotic sites (bariatric surgery, tumor resection), vascular postsurgical edema, or concern for perforation. 1

Modalities to AVOID:

Fluoroscopy with barium or iodinated oral contrast has NO role in acute UGIB evaluation. 1

  • Positive oral contrast obscures active hemorrhage and interferes with subsequent endoscopy, angiography, or CT. 1

Tc-99m-labeled RBC scanning has limited utility in UGIB. 1

  • High false-positive and false-negative rates specifically for upper GI sources. 1
  • Errors in localization frequently occur with gastric or duodenal bleeding. 1
  • Can detect bleeding as slow as 0.05-0.1 mL/min but diagnostic efficacy is widely variable. 1

Management After Failed Endoscopic Hemostasis

If endoscopic therapy fails, attempt transcatheter arterial embolization before proceeding to surgery. 4, 3

  • For recurrent bleeding, repeat endoscopy is suggested first. 3
  • If second endoscopic attempt fails, transcatheter embolization is the next step. 3

Post-Endoscopy Management

After successful endoscopic hemostasis, administer high-dose proton pump inhibitor therapy continuously or intermittently for 72 hours, then twice-daily oral PPI for the first 2 weeks. 4, 3

  • This timing is critical as rebleeding risk is highest in the first 72 hours post-endoscopy. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Gastrointestinal Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding.

The American journal of gastroenterology, 2021

Research

Timing of Endoscopy for Acute Upper Gastrointestinal Bleeding.

The New England journal of medicine, 2020

Research

Management of acute upper gastrointestinal bleeding.

BMJ (Clinical research ed.), 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.